0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Viewpoint | 
Arjun K. Manrai, PhD; John P. A. Ioannidis, MD, DSc; Isaac S. Kohane, MD, PhD
JAMA. 2016;315(12):1233-1234. doi:10.1001/jama.2016.1519.

Viewpoint | 
Steven J. Katz, MD, MPH; Allison W. Kurian, MD, MSc; Monica Morrow, MD
JAMA. 2015;314(10):997-998. doi:10.1001/jama.2015.8088.

Editorial | 
Roberto Romero, MD, DMedSci; Maurice J. Mahoney, MD, JD
JAMA. 2015;314(2):131-133. doi:10.1001/jama.2015.7523.

Preliminary Communication |  FREE
Diana W. Bianchi, MD; Darya Chudova, PhD; Amy J. Sehnert, MD; et al.
JAMA. 2015;314(2):162-169. doi:10.1001/jama.2015.7120.

News From the Food and Drug Administration | 
Rita Rubin, MA
JAMA. 2015;313(13):1306. doi:10.1001/jama.2015.2809.

Medical News & Perspectives | 
Ricki Lewis, PhD
JAMA. 2015;313(13):1301-1303. doi:10.1001/jama.2015.1389.

Viewpoint | 
Joshua Sharfstein, MD
JAMA. 2015;313(7):667-668. doi:10.1001/jama.2014.18135.

Viewpoint | 
James P. Evans, MD, PhD; Michael S. Watson, PhD
JAMA. 2015;313(7):669-670. doi:10.1001/jama.2014.18145.

From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2014;312(23):2566. doi:10.1001/jama.2014.15746.

Editorial | 
Jonathan S. Berg, MD, PhD
JAMA. 2014;312(18):1865-1867. doi:10.1001/jama.2014.14665.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Dermatology
Editorial  | 
Genotypic Heterogeneity and the Mode of Inheritance in Epidermolysis Bullosa
Jouni Uitto, MD, PhD; Hassan Vahidnezhad, MSc; Leila Youssefian, MSc
JAMA Otolaryngology–Head & Neck Surgery
Viewpoint  | 
Utility of Diagnostic Molecular Markers for Evaluation of Indeterminate Thyroid Nodules
Russell B. Smith, MD; Robert L. Ferris, MD, PhD
JAMA Oncology
Viewpoint  | 
PD-L1 Testing and Lack of Benefit to Guide Treatment With Immune Checkpoint Inhibitors in Patients With Non–Small-Cell Lung Cancer
Nathan A. Pennell, MD, PhD
JAMA Oncology
Viewpoint  | 
The Value of PD-L1 Testing in Non–Small-Cell Lung Cancer
Aaron Lisberg, MD; Edward B. Garon, MD